Hereditary Bullous Dystrophy, Macular Type

Hereditary Bullous Dystrophy, Macular Type is a rare eye disease that you are born with. It mainly affects the clear front window of the eye called the cornea. Over many years, cloudy material builds up inside the cornea. This makes the cornea look hazy and can slowly reduce vision. The cloudiness usually starts as small, ill-defined gray-white spots in the middle layers of the cornea (the stroma). With time, the haze spreads and can involve most of the cornea. Some people also develop corneal thinning and irregular shape, which further blurs vision. MCD is caused by changes (mutations) in a gene called CHST6 and is passed down in families in an autosomal recessive pattern. That means a person needs two changed copies of the gene—one from each parent—to develop the disease. orpha.net+2EyeWiki+2

Macular corneal dystrophy (MCD) is a rare, inherited eye disease that slowly makes the clear window of the eye (the cornea) cloudy. Tiny deposits build up in the middle layers of the cornea and can also spread deeper. Because the cornea becomes hazy and thinner, light cannot pass through clearly, so vision becomes blurry and glare increases. MCD usually affects both eyes, often starting in childhood or young adult life, and it tends to get worse over time. It is autosomal recessive, which means a person usually needs to inherit the changed gene from both parents. The key gene is CHST6; when this gene does not work properly, the cornea makes keratan sulfate incorrectly, and abnormal glycosaminoglycans collect in corneal cells and tissue. There is no medicine that stops the disease, so treatment focuses on comfort and clear vision—first with drops and lenses, and later with corneal surgery when vision is badly reduced. SpringerOpen+3orpha.net+3PMC+3

In MCD, corneal support cells (keratocytes) and sometimes the endothelial layer collect abnormal glycosaminoglycans because keratan sulfate is not sulfated normally. These deposits scatter light and reduce the cornea’s natural clarity. Over time, the stromal layer becomes hazy with “spots” that merge, the cornea can thin, and deeper layers can become involved, making vision worse. Genetic studies show many different harmful changes in CHST6, all leading to faulty keratan sulfate processing. PMC+2FEBS Journal+2

Scientists know that CHST6 helps add sulfate groups to a corneal sugar called keratan sulfate. When CHST6 does not work properly, keratan sulfate is not sulfated correctly. Abnormal glycosaminoglycans then accumulate inside the cornea, which leads to the typical haze and opacities. This is why MCD is sometimes described as a disorder of “abnormal proteoglycan” or “keratan sulfate” metabolism. SpringerOpen+1

Although MCD is categorized as a stromal corneal dystrophy, other corneal layers (Descemet’s membrane and the endothelium) can also be involved in many patients. This broader involvement helps explain corneal thinning and advanced clouding in some cases. EyeWiki

---

Other names

• Macular corneal dystrophy (MCD) – the preferred modern name. orpha.net+1

• Groenouw type II corneal dystrophy / Fehr corneal dystrophy – historic names from early descriptions. Wikipedia

• Stromal corneal dystrophy, macular type – emphasizes the main corneal layer affected. BioMed Central

• CHST6-related corneal dystrophy – genetic descriptor used in some labs and registries. NCBI

• “Hereditary bullous dystrophy, macular type” – an outdated term sometimes seen in older literature; today, “macular corneal dystrophy” is used. BioMed Central

---

Types

Doctors recognize immunologic subtypes based on whether sulfated keratan sulfate is detectable in blood/tear/corneal tissue:

1. Type I (classic)
   Keratan sulfate is absent on special tests and staining. Clinically it looks like typical MCD with progressive stromal haze and opacities. NCBI

2. Type II
   Keratan sulfate is present on testing, but the pattern is still abnormal. Symptoms and clinical appearance are very similar to type I. NCBI

(Researchers have also described rarer immunohistochemical variants that reflect differences in where and how abnormal material accumulates, but in everyday care types I and II are the main categories.) ScienceDirect

---

Causes

MCD is an inherited disease with one root cause—pathogenic variants in CHST6. Below are 20 concrete genetic, molecular, and population-level factors that cause or contribute to the condition’s development or severity.

1. Loss-of-function CHST6 variants (frameshift, nonsense, severe missense) that abolish enzyme activity, leading to absent sulfation of keratan sulfate. PMC

2. Missense CHST6 variants that reduce but do not completely eliminate enzyme function, allowing some residual activity yet still causing disease. PMC

3. Promoter or upstream region mutations/deletions that reduce cornea-specific CHST6 expression. IOVS

4. Compound heterozygosity (different pathogenic variants on each allele) causing overall enzyme deficiency. PMC

5. Homozygosity for a founder mutation in certain populations (e.g., Iceland, parts of India, Middle East) increasing disease frequency. Nature+1

6. Autosomal recessive inheritance requiring two pathogenic alleles to express disease. NCBI

7. Consanguinity (parents related by blood) raising the chance of inheriting two pathogenic CHST6 alleles. SpringerOpen

8. Abnormal keratan sulfate biosynthesis leading to storage of glycosaminoglycans in stromal keratocytes. SpringerOpen+1

9. Disordered proteoglycan organization disrupting corneal collagen spacing and transparency. Taylor & Francis Online

10. Endothelial layer participation in some patients, compounding haze and edema risk. EyeWiki

11. Progressive stromal accumulation over time, which naturally worsens vision with age. EyeWiki

12. Corneal thinning in MCD that increases irregular astigmatism and optical scatter. Nature

13. Inflammation after epithelial erosions (secondary) that can temporarily aggravate symptoms. (General corneal dystrophy symptom mechanisms.) AAO

14. Cell turnover and wound-healing responses that deposit more abnormal matrix after minor trauma or surgery. BioMed Central

15. Tissue-level heterogeneity of deposits (not all deposits are identical), influencing staining and severity. ScienceDirect

16. Modifier genes/environment are minimal compared with the core CHST6 effect, but may influence timing of onset slightly. (Overview of dystrophy genetics.) BioMed Central

17. Biochemical “keratan sulfate negative” state (Type I) that correlates with more widespread stromal involvement in some series. NCBI

18. Specific regional mutations expanding the known spectrum (e.g., novel variants in Asian cohorts) that cause classic MCD. PMC+1

19. CHST6 variant effect on endothelial function suggested by newer research, possibly shaping disease expression. MedRxiv

20. Natural history without treatment—the continual build-up of deposits itself functions as the driving “cause” of progressive visual loss. EyeWiki

---

Symptoms

1. Blurry vision – Haze and deposits scatter light, so fine details become hard to see, first at distance and later at near. EyeWiki

2. Glare and halos – Bright lights seem to “bloom” or create rings because the cornea is not perfectly clear. EyeWiki

3. Light sensitivity (photophobia) – Light entering a cloudy cornea causes discomfort and squinting. AAO

4. Foreign-body sensation – The eye may feel gritty or as if something is in it, especially if small surface erosions occur. AAO

5. Eye pain – Pain can occur during episodes of surface breakdown (recurrent corneal erosions). AAO

6. Tearing – Watery eyes are a reflex response to surface irritation and light sensitivity. AAO

7. Redness – The eye can look red during symptomatic flares from surface irritation. AAO

8. Reduced contrast sensitivity – Washed-out or low-contrast scenes are harder to see clearly due to light scatter. EyeWiki

9. Worse vision at night – Headlights and low light make scatter and irregular optics more obvious. EyeWiki

10. Fluctuating vision – Vision can vary day to day with surface moisture, minor erosions, or tear film quality. AAO

11. Recurrent corneal erosions – The surface layer can loosen in spots, causing sharp pain and tearing on waking. AAO

12. Astigmatism changes – Thinning and irregular shape can alter glasses prescriptions over time. Nature

13. Hazy corneas on inspection – A doctor can see diffuse haze and focal cloudy spots with a slit lamp. AAO+1

14. Slow, lifelong progression – Symptoms usually start in childhood or teens and worsen over decades. Wikipedia

15. Reduced best-corrected vision in later stages – Even with glasses or contacts, vision may remain limited when haze is dense. EyeWiki

---

Diagnostic tests

A) Physical examination

1. Visual acuity testing
   You read letters on a chart. This measures how clearly you see. In MCD, acuity gradually declines as haze increases. EyeWiki

2. Pinhole test
   A small pinhole can reduce the effect of refractive errors. If vision does not improve much, the problem is corneal clarity rather than glasses strength. (General clinical method in corneal disease.) NCBI

3. External eye and penlight exam
   A basic look at the eyes can show corneal dullness or opacity. It is a quick screening before detailed tests. NCBI

4. Confrontation visual fields
   A quick check of side vision helps rule out other eye disorders; MCD mainly affects clarity, not fields. NCBI

5. Intraocular pressure (tonometry)
   Eye pressure is measured because chronic irritation and planned surgeries require a full baseline eye health check. NCBI

B) Manual / clinical chair-side tests

6. Slit-lamp biomicroscopy
   This is the key exam. The doctor uses a microscope with a bright beam to see the ill-defined gray-white stromal opacities and the general stromal haze typical of MCD. EyeWiki+1

7. Fluorescein staining of the corneal surface
   A dye highlights any surface erosions and helps explain pain or tearing episodes. AAO

8. Corneal esthesiometry (sensation testing)
   A thin fiber or device touches the cornea to check sensitivity, which may be altered in chronically diseased corneas. (General dystrophy evaluation.) NCBI

9. Glare disability and contrast sensitivity tests
   These measure real-world effects of scatter from corneal haze. Patients with MCD often show reduced contrast and more glare. EyeWiki

10. Keratometry / manual refraction
    These assess how the cornea focuses light and determine glasses changes as shape becomes irregular over time. NCBI

C) Laboratory / pathological tests

11. Genetic testing for CHST6
    Testing confirms pathogenic variants. It also helps counsel family members about inheritance and recurrence risk. The NIH Genetic Testing Registry lists CHST6 tests for MCD. NCBI

12. Special histologic stains on corneal tissue
    If a corneal transplant (“button”) is examined, alcian blue or colloidal iron stains highlight glycosaminoglycan deposits that define MCD. AAO+1

13. Keratan sulfate immunoassays / immunostaining
    These tests differentiate Type I (KS-negative) from Type II (KS-positive) disease in serum/tears/tissue. NCBI

14. Electron microscopy (research/confirmation setting)
    Ultra-thin sections of cornea can show fine structural changes and where the deposits sit among collagen fibrils. BioMed Central

15. Family studies / segregation analysis
    Testing parents and siblings can document autosomal recessive inheritance and identify carriers in affected families. NCBI

D) Electrodiagnostic tests

16. Electroretinography (ERG)
    This test measures retinal function. It is usually normal in MCD and helps rule out retinal diseases when vision seems worse than corneal haze suggests. (General ophthalmic practice.) NCBI

17. Electro-oculography (EOG)
    This assesses the retinal pigment epithelium. Like ERG, it is typically normal in isolated corneal disease and is used only if the doctor suspects another diagnosis. (General principle.) NCBI

E) Imaging tests

18. Anterior segment optical coherence tomography (AS-OCT)
    AS-OCT makes cross-section images of the cornea and shows the depth and extent of stromal deposits and haze. It can also document corneal thinning. Nature

19. In vivo confocal microscopy
    This “optical biopsy” images living corneal layers at near-cellular detail and can visualize abnormal deposits and keratocyte changes in MCD. EyeWiki

20. Corneal topography/tomography (e.g., Scheimpflug)
    Maps corneal shape and curvature. It can reveal irregular astigmatism and quantify progression over time. Nature

21. Pachymetry
    Measures corneal thickness; many MCD corneas become thinner than normal. Nature

22. Specular microscopy
    Counts and assesses endothelial cells. Because the endothelium can be involved in MCD, this test informs surgical planning. EyeWiki

23. High-resolution slit-lamp photography
    Standardized photos track changes in opacities and haze across visits and aid counseling. AAO

24. Ultrasound biomicroscopy (when needed)
    Uses high-frequency ultrasound to image deeper structures if OCT is limited by dense haze. (Imaging overview.) NCBI

25. Tear film tests (TBUT/Schirmer) as adjuncts
    Dry eye can worsen glare and discomfort; testing helps separate surface symptoms from dystrophy-related changes. AAO

Non-pharmacological treatments (therapies and other measures)

1. Education, lighting, and glare control
   Description. Teach simple habits: use brighter, even room light; avoid oncoming headlights; enlarge print on phones; use high-contrast settings on screens. These steps reduce scattering and increase comfort. Purpose. Ease daily strain and improve function while the disease progresses slowly. Mechanism. Glare filters and better lighting increase the signal-to-noise ratio at the retina. High-contrast fonts and larger text fight the loss of contrast sensitivity caused by stromal haze. Polarized sunglasses and antireflective coatings reduce reflected glare from the hazy corneal surface. These measures do not change the disease but make vision more usable in real-world settings and often delay the point when surgery feels necessary. EyeWiki

2. UV-blocking sunglasses outdoors
   Description. Wear wraparound sunglasses with UV400 protection. Purpose. Reduce light sensitivity and squinting; improve comfort and contrast. Mechanism. UV and high-energy visible light increase scatter in a hazy cornea; filtering reduces photophobia and improves contrast perception, making daily tasks (driving, walking, reading signs) easier. EyeWiki

3. Frequent preservative-free artificial tears (daytime)
   Description. Lubricant drops add a smooth tear film over an irregular surface, improving clarity briefly and comfort long-term. Purpose. Reduce irritation and fluctuating blur. Mechanism. A stable tear layer decreases micro-scatter at the corneal surface and dilutes inflammatory mediators. (OTC lubricants are discussed under drugs as well.) EyeWiki

4. Nighttime gel or ointment
   Description. Thicker lubricants before bed protect the surface during sleep, when blinking stops. Purpose. Prevent morning pain and blur linked to micro-erosions. Mechanism. A viscous layer shields epithelium from friction and desiccation, lowering the chance of recurrent erosions. EyeWiki

5. Bandage soft contact lens for recurrent erosions (short courses)
   Description. Doctors sometimes place a sterile soft lens for days to weeks when the surface keeps breaking down. Purpose. Pain relief while the epithelium heals. Mechanism. The lens acts like a “skin,” reducing friction from blinking and creating a protected micro-environment that favors re-epithelialization; antibiotic drops may be added to reduce infection risk. EyeWiki

6. Rigid gas-permeable (RGP) or scleral lenses for optics
   Description. Specialty lenses give a new smooth optical surface. Purpose. Improve quality of vision in moderate disease when glasses no longer help. Mechanism. A tear reservoir under an RGP/scleral lens neutralizes anterior stromal irregularities, decreasing higher-order aberrations and improving contrast and acuity without surgery. EyeWiki

7. Saline rinses and eyelid hygiene
   Description. Gentle preservative-free saline rinses and warm compresses keep the ocular surface clean and comfortable. Purpose. Reduce secondary irritation and fluctuating blur. Mechanism. A cleaner lid margin and stable oil layer reduce tear evaporation; less surface dryness means less light scatter over an already hazy cornea. EyeWiki

8. Temporary hypertonic saline (non-Rx measure supervised by a clinician)
   Description. Short trial of 5% sodium chloride drops or ointment (see drugs below) is sometimes used for symptomatic edema-like symptoms. Purpose. Draw fluid out of the corneal surface to reduce morning blur. Mechanism. Osmotic effect pulls water from the cornea to the tears, reducing epithelial edema that worsens scatter. (Labeling indicates use for corneal edema; clinicians apply it symptom-guided.) DailyMed+1

9. Treat dry eye contributors
   Description. Address meibomian gland dysfunction with warm compresses and blink training; consider punctal occlusion if aqueous-deficient, per clinician. Purpose. A better tear film supports clearer, more comfortable vision. Mechanism. Improved tear stability reduces fluctuating blur and surface micro-defects that magnify haze symptoms. EyeWiki

10. Workstation and reading ergonomics
    Description. Increase font size, raise screen brightness moderately, and use matte screens. Purpose. Reduce eye strain and maximize useful vision. Mechanism. Ergonomics reduce reliance on low-contrast detail that is hardest for a hazy cornea to resolve. EyeWiki

11. Protective eyewear
    Description. Use safety glasses during yard work, DIY projects, or dusty jobs. Purpose. Prevent minor abrasions that worsen erosions and haze. Mechanism. A physical barrier reduces trauma to vulnerable epithelium. EyeWiki

12. Low-vision aids (when needed)
    Description. Handheld magnifiers, electronic magnifiers, high-contrast e-readers, and text-to-speech tools. Purpose. Maintain independence until surgery is chosen. Mechanism. Magnification and contrast enhancement overcome the optical noise from stromal haze. EyeWiki

13. Smoking avoidance and air-quality control
    Description. Keep indoor air humidified; avoid smoke and fumes. Purpose. Reduce surface irritation that aggravates blur. Mechanism. Particulates and dry air destabilize the tear film; reducing them improves surface optics. EyeWiki

14. Manage systemic contributors (if any)
    Description. Rarely, coexisting systemic mucopolysaccharidoses may be considered in the differential; ongoing medical care helps overall eye comfort. Purpose. Global health supports ocular surface wellness. Mechanism. Reducing systemic inflammation or dryness improves tear quality. EyeWiki

15. Regular follow-up and timing of surgery
    Description. Scheduled visits track acuity, corneal thickness, deposit depth, and symptoms. Purpose. Choose surgery at the right moment—when daily life is limited. Mechanism. Objective measures plus patient-reported outcomes guide when to proceed to DALK/PKP. EyeWiki

16. Phototherapeutic keratectomy (PTK) as a bridge
    Description. In select cases with superficial issues or recurrent erosions, PTK can smooth the surface. Purpose. Delay keratoplasty and reduce painful erosions. Mechanism. The excimer laser precisely removes microns of tissue and polishes the anterior stroma, but it does not halt deep disease. EyeWiki

17. Femtosecond-assisted lamellar smoothing (selected cases)
    Description. Laser-guided lamellar removal of opacified tissue to buy time. Purpose. Temporary clarity boost. Mechanism. Creates a smoother optical interface but cannot reverse deep stromal involvement. EyeWiki

18. Psychosocial support and vision counseling
    Description. Coaching for driving decisions, workplace accommodations, and device accessibility. Purpose. Reduce anxiety and maintain independence. Mechanism. Practical strategies mitigate the life impact of slowly progressive vision loss. EyeWiki

19. Nutrition and hydration for surface health
    Description. Encourage balanced diet and adequate fluids to support tears. Purpose. Support a healthier ocular surface. Mechanism. Adequate hydration supports tear volume; omega-3-rich foods may support meibomian oil quality (general dry-eye measure). EyeWiki

20. Genetic counseling for families
    Description. Because MCD is autosomal recessive, counseling helps families understand risks to children and relatives and the value of early eye checks. Purpose. Plan screening and support. Mechanism. Understanding inheritance patterns improves early detection and timely care. orpha.net

---

Drug treatments

Important context: No medicine stops or reverses MCD. Drops mainly support comfort, stabilize the surface, or treat complications. Some are used short-term around procedures. Labeling below is for their approved indications; clinicians apply them to manage symptoms or peri-operative care in MCD.

1. Hypertonic sodium chloride 5% drops
   Class. Hypertonicity agent. Dose/Timing. Often 1–2 drops as needed or as directed; typical labels: up to four times daily. Purpose. Temporary relief when epithelial swelling worsens blur on waking. Mechanism. Osmotic gradient pulls fluid out of the cornea, reducing micro-edema and scatter. Side effects. Temporary stinging/irritation. Label source. DailyMed OT C labels for 5% sodium chloride (e.g., MURO 128). DailyMed+1

2. Hypertonic sodium chloride 5% ointment (bedtime)
   Class. Hypertonicity agent. Dose/Timing. Apply at bedtime; sometimes also on waking. Purpose. Reduce morning blur and pain. Mechanism. Prolonged contact time sustains osmotic dehydration overnight. Side effects. Temporary blur, irritation. Label source. DailyMed MURO 128 and similar listings. DailyMed+1

3. Carboxymethylcellulose 0.5% artificial tears (PF)
   Class. Lubricant. Dose/Timing. 1–2 drops as needed; frequent PF use favored. Purpose. Smoother surface and comfort. Mechanism. Increases tear film thickness and stability, lowering surface scatter. Side effects. Rare irritation. Label source. DailyMed Refresh/CMC labels. DailyMed+1

4. Polyethylene glycol/propylene glycol lubricants (e.g., Systane Ultra)
   Class. Lubricants. Dose/Timing. As needed up to QID or more per label. Purpose. Surface protection and symptom relief. Mechanism. Demulcent polymers form a protective layer, smoothing micro-irregularities. Side effects. Temporary blur/irritation. Label source. DailyMed Systane labels. DailyMed+1

5. Cyclosporine ophthalmic 0.05% (Restasis®)
   Class. Topical calcineurin inhibitor. Dose/Timing. 1 drop BID ~12 hours apart. Purpose. In dry eye patients with inflammatory tear deficiency, may improve baseline lubrication (adjunctive in MCD). Mechanism. Reduces ocular surface inflammation to increase tear production in indicated patients. Side effects. Burning, stinging. Label source. FDA label. FDA Access Data

6. Lifitegrast 5% (Xiidra®)
   Class. LFA-1 antagonist for dry eye disease. Dose/Timing. 1 drop BID ~12 hours apart. Purpose. Treat concomitant dry-eye signs/symptoms to improve comfort and functional vision. Mechanism. Blocks LFA-1/ICAM-1 interaction to reduce ocular surface inflammation. Side effects. Dysgeusia, irritation. Label source. FDA label. FDA Access Data

7. Prednisolone acetate 1% (short courses, medical supervision)
   Class. Ophthalmic corticosteroid. Dose/Timing. Tapered per clinician for erosions/inflammation or post-procedures. Purpose. Calm surface inflammation and pain; essential after keratoplasty. Mechanism. Inhibits inflammatory mediators. Side effects. IOP rise, cataract risk, infection risk. Label source. Pred Forte/Omnipred labels. FDA Access Data+1

8. Antibiotic drops for erosions or peri-operative use (e.g., moxifloxacin 0.5%)
   Class. Fluoroquinolone antibiotic. Dose/Timing. Per label (often QID; peri-op protocols vary). Purpose. Prevent/treat bacterial infection when epithelium is compromised or around surgery. Mechanism. Inhibits bacterial DNA gyrase/topoisomerase. Side effects. Burning, hypersensitivity. Label source. VIGAMOX label. FDA Access Data

9. Ofloxacin 0.3% (alternative fluoroquinolone)
   Class. Fluoroquinolone antibiotic. Dose/Timing. Per label regimens. Purpose. Similar to #8 when needed. Mechanism. Inhibits bacterial DNA replication. Side effects. Irritation, hypersensitivity. Label source. OCUFLOX label. FDA Access Data

10. Levofloxacin 1.5% (IQUIX®) for corneal infection risk scenarios
    Class. Fluoroquinolone antibiotic. Dose/Timing. Per label. Purpose. Coverage for bacterial keratitis scenarios. Mechanism. Inhibits DNA gyrase/topoisomerase. Side effects. Irritation. Label source. IQUIX label. FDA Access Data

11. Non-preserved lubricating gel (night use)
    Class. Lubricant gel. Dose/Timing. HS and PRN. Purpose. Protect surface overnight. Mechanism. Prolonged retention; smoother optics on waking. Side effects. Temporary blur. Label source. Representative OTC labels (Systane Gel). DailyMed

12. Antibiotic/steroid combinations (short, selected)
    Class. Combo anti-infective/anti-inflammatory. Dose/Timing. Brief courses per clinician after erosions/procedures. Purpose. Reduce pain/inflammation and infection risk. Mechanism. Dual action on bacteria and inflammation. Side effects. IOP rise, delayed healing. Label source. PRED-G labeling. FDA Access Data

13. NSAID eye drops (short-term, selected cases)
    Class. Topical NSAID. Dose/Timing. Short courses per clinician for pain control. Purpose. Reduce discomfort from surface irritation/erosions. Mechanism. COX inhibition to lower prostaglandins. Side effects. Rare corneal complications with prolonged use. Evidence. Not disease-modifying; used symptomatically alongside standard care. EyeWiki

14. Peri-operative dilating/antiseptic drops (for surgery days)
    Class. Mydriatics/antiseptics per surgical protocol. Purpose. Safe and sterile surgery. Mechanism. Pupil control/antisepsis. Side effects. Transient stinging or photophobia. Evidence. Standard corneal surgery practice patterns. EyeWiki

15. Post-keratoplasty steroid regimen (long-term)
    Class. Corticosteroids. Dose/Timing. Tapered over months; sometimes low-dose maintenance. Purpose. Prevent graft rejection and control inflammation. Mechanism. Suppresses immune response against graft. Side effects. IOP rise, cataract. Label source. Prednisolone acetate labeling; clinical practice for keratoplasty. FDA Access Data

16. Lubricant ointments (PF) for severe surface symptoms
    Class. Petrolatum/mineral oil-based ocular lubricants. Dose/Timing. HS and PRN. Purpose. Comfort and epithelial protection. Mechanism. Occlusive barrier reduces evaporation and friction. Evidence. OTC labels parallel tear products. DailyMed

17. Antibiotic prophylaxis with bandage lens
    Class. Topical antibiotic. Dose/Timing. As per clinician while bandage lens is in place. Purpose. Reduce infection risk. Mechanism. Decrease bacterial load under lens. Label source. Fluoroquinolone labels (moxifloxacin/ofloxacin). FDA Access Data+1

18. Post-PTK medication bundle
    Class. Steroid + antibiotic + lubricants. Dose/Timing. Short protocol after laser smoothing. Purpose. Promote smooth healing and prevent infection. Mechanism. As above (#7–#9). Evidence. Standard PTK aftercare. EyeWiki

19. Dry eye anti-inflammatories (chronic adjunct) — cyclosporine/lifitegrast
    Class. See #5–#6. Purpose. Reduce surface inflammation that amplifies glare/blur. Mechanism. Immune modulation. Labels. FDA. FDA Access Data+1

20. Patient-directed OTC plans (under clinician guidance)
    Class. OTC lubricants and hypertonics. Dose/Timing. Per label. Purpose. Empowered home care to delay surgery. Mechanism. Surface optimization. Labels. DailyMed entries. DailyMed+1

---

Dietary molecular supplements

No supplement treats or reverses MCD. These are general ocular surface/dry-eye supports discussed with clinicians. Doses are typical consumer doses; individual advice may differ.

1. Omega-3 fatty acids (fish/plant sources)
   Dose. Commonly 1–2 g/day EPA+DHA (dietary focus preferred). Function. Support meibomian oil quality and tear stability. Mechanism. Anti-inflammatory effects on ocular surface lipids may reduce evaporative dryness, easing glare/blur over a hazy cornea. (Adjunctive only.) EyeWiki

2. Vitamin A (dietary, not high-dose supplements unless prescribed)
   Dose. RDA-level intake through food. Function. Supports epithelial health. Mechanism. Adequate vitamin A helps surface integrity, lowering erosion risk. (Avoid excess.) EyeWiki

3. Vitamin D (correct deficiency)
   Dose. As per lab results and clinician advice. Function. General immune/epithelial support. Mechanism. Adequate vitamin D may help ocular surface homeostasis. EyeWiki

4. Hydration (water intake)
   Dose. Meet daily hydration goals. Function. Maintain tear volume. Mechanism. Proper hydration supports aqueous tear production and comfort. EyeWiki

5. Flaxseed (ALA source)
   Dose. 1–2 Tbsp ground flax/day. Function. Plant omega-3 for tear stability. Mechanism. Anti-inflammatory lipid profile supports meibomian function. EyeWiki

6. Antioxidant-rich foods (berries/leafy greens)
   Dose. Daily servings. Function. General ocular health. Mechanism. Antioxidants support epithelial resilience; not MCD-specific but helpful for surface comfort. EyeWiki

7. L-carnitine (dietary sources)
   Dose. Food-based approach. Function. General cellular energy support. Mechanism. May aid epithelial metabolism; no MCD-specific evidence. EyeWiki

8. Zinc (adequate, not excessive)
   Dose. RDA level. Function. Supports epithelial healing and immune function. Mechanism. Cofactor for repair enzymes; avoid high doses. EyeWiki

9. Curcumin-containing foods
   Dose. Culinary amounts. Function. Systemic anti-inflammatory effects may help comfort. Mechanism. NF-κB modulation; adjunct only. EyeWiki

10. Probiotic-rich foods
    Dose. Regular servings. Function. Gut-eye axis support (general). Mechanism. Systemic immune balance may reduce surface irritation triggers. EyeWiki

---

Drug as immunity booster / regenerative / stem-cell-related

There are no approved “immunity-boosting,” regenerative, or stem-cell drugs for MCD. Research areas include gene and enzyme replacement concepts, but these are not clinical treatments yet. After corneal transplant, the “regenerative” improvement comes from the donor tissue, not a systemic drug. Below are realistic, clinically relevant items related to immune modulation and regeneration context, phrased carefully.

1. Topical cyclosporine 0.05%
   100-word description. Used for dry eye with inflammatory basis, cyclosporine reduces surface inflammation, improves tear production, and can make the corneal surface healthier for patients with MCD-related glare and irritation. Dose. 1 drop BID. Function. Immune modulation of ocular surface. Mechanism. Calcineurin inhibition lowers T-cell activity on the ocular surface. FDA Access Data

2. Topical lifitegrast 5%
   Description. For dry eye signs/symptoms; may improve comfort in MCD by reducing surface inflammation. Dose. 1 drop BID. Function. Immune modulation. Mechanism. Blocks LFA-1/ICAM-1 interaction to reduce T-cell-mediated inflammation. FDA Access Data

3. Post-keratoplasty corticosteroids (e.g., prednisolone acetate 1%)
   Description. After transplant, long-term low-dose steroids prevent immune rejection of the graft, protecting the “regenerative” clarity provided by donor tissue. Dose. Taper then maintenance per surgeon. Function. Immune suppression at the graft. Mechanism. Broad anti-inflammatory effects. FDA Access Data

4. Supportive ocular surface regimen (PF lubricants)
   Description. While not an immune drug, consistent lubrication helps epithelial healing and graft health. Dose. Frequent PF tears and HS gel. Function. Surface protection to support regeneration. Mechanism. Mechanical protection and dilution of inflammatory mediators. DailyMed

5. Future gene therapy concepts (research stage)
   Description. Early work in gene editing in other corneal dystrophies suggests potential routes for MCD in the future; currently experimental only. Dose/Function/Mechanism. Would target the defective gene pathway (CHST6), but this is not available clinically. EyeWiki

6. (Clarifying non-availability)
   Description. There are no approved systemic “stem-cell drugs” for MCD. Regeneration comes from surgical tissue replacement (grafts). Function/Mechanism. Donor cornea provides clear stroma/endothelium; the patient’s immune system is managed locally to protect it. EyeWiki

---

Surgeries (procedures and why they’re done)

1. Penetrating Keratoplasty (PKP)
   Procedure. Full-thickness corneal transplant: surgeon removes a circular plug of diseased cornea and sews in a clear donor cornea. Why. Gold-standard for advanced MCD, especially when deep stroma/Descemet/endothelium are involved. Outcomes. Strong visual gains; long-term graft survival is good, though disease can recur in the graft years later, and some need repeat PKP. EyeWiki

2. Deep Anterior Lamellar Keratoplasty (DALK)
   Procedure. Partial-thickness transplant replacing stroma but keeping the patient’s own Descemet membrane and endothelium. Why. Good option when endothelium is not involved; lowers endothelial rejection risk. Outcomes. Visual results can rival PKP in appropriate cases. Choice depends on depth of deposits. EyeWiki+1

3. Phototherapeutic Keratectomy (PTK)
   Procedure. Excimer laser polishes/smooths the front cornea, removing superficial haze or treating recurrent erosions. Why. Temporary clarity and symptom relief; can delay keratoplasty. Limits. Not effective for deep disease; may need repeat. EyeWiki

4. Femtosecond Laser–Assisted Lamellar Debulking
   Procedure. Laser creates a precise lamellar plane to remove anterior opacities. Why. Selected cases to improve optics when disease is not deeply seated. Limits. Benefit modest and temporary if deeper layers are affected. EyeWiki

5. Repeat Keratoplasty (if recurrence or graft failure)
   Procedure. Redo PKP or DALK if the graft becomes cloudy or fails. Why. Maintain vision if recurrence or scarring threatens clarity. Outcomes. Many regain useful vision; lifetime follow-up is essential. EyeWiki

---

Preventions

There is no proven primary prevention for MCD because it is genetic. But you can prevent avoidable worsening and protect the surface:

1. Use UV-blocking sunglasses outdoors to reduce glare and photophobia. EyeWiki

2. Do not rub your eyes; rubbing worsens erosions. EyeWiki

3. Keep a regular lubrication habit (PF tears by day, gel at night). EyeWiki

4. Use humidifiers and avoid smoke/fumes to protect the tear film. EyeWiki

5. Wear eye protection for dusty/impact-risk tasks. EyeWiki

6. Treat dry eye contributors (warm compresses/blink hygiene). EyeWiki

7. Follow up regularly to time surgery appropriately. EyeWiki

8. Be consistent with post-surgical medicines to protect the graft. EyeWiki

9. Manage screen ergonomics—bigger fonts, better lighting. EyeWiki

10. Family counseling so relatives at risk get early eye checks. orpha.net

---

When to see a doctor

See an eye doctor promptly if: vision worsens noticeably; glare makes night driving unsafe; you have new eye pain or recurrent erosions; redness or discharge develops; recovery after a surface scratch is slow; you need to discuss timing of surgery because daily activities are limited; or you have a family history of MCD and want screening for yourself or your children. Regular, scheduled visits (even when stable) help choose the right moment for DALK or PKP and protect long-term vision. EyeWiki

---

Foods to favor and to limit

Eat more:

1. Oily fish (omega-3s),

2. flax/chia,

3. leafy greens,

4. colorful berries,

5. nuts (if not allergic),

6. whole grains,

7. citrus/kiwi (vitamin C),

8. carrots/squash (vitamin A precursors),

9. legumes,

10. plenty of water. These support general ocular surface health and tear stability. EyeWiki

Limit:

1. Very dry/salty snacks (dehydrating),

2. excessive caffeine/alcohol (can dry you),

3. smoke exposure,

4. ultra-processed foods high in trans-fats,

5. spicy fumes if they trigger irritation,

6. dusty cooking environments without ventilation,

7. low-hydration routines,

8. harsh indoor air (use humidifiers),

9. frequent late-night screen time without breaks,

10. eye-rubbing habits. These steps won’t cure MCD but can make eyes more comfortable. EyeWiki

---

FAQs

1) Is MCD the same as “hereditary bullous dystrophy, macular type”?
The modern term is Macular Corneal Dystrophy. Historical labels vary, which causes confusion; MCD is the accurate name used today. orpha.net

2) Is it inherited?
Yes, autosomal recessive—usually both parents are carriers. Family members may benefit from eye checks and counseling. orpha.net

3) What gene is involved?
Most cases involve CHST6, which changes how keratan sulfate is made and processed. PMC

4) Can eye drops cure it?
No. Drops help comfort and surface quality, but surgery restores clarity when vision is badly reduced. EyeWiki

5) What surgeries work?
PKP (full-thickness transplant) and DALK (partial-thickness) are the main options; choice depends on depth of disease. EyeWiki

6) Does the disease come back after a transplant?
It can recur in the graft over years; careful follow-up is important. EyeWiki

7) Which is better—PKP or DALK?
Both can give excellent vision. If the endothelium is healthy, DALK lowers rejection risk; if deeper layers are involved, PKP may be favored. EyeWiki+1

8) Are there future cures?
Research explores enzyme replacement and gene therapy, but these are not yet clinical care. EyeWiki

9) Do I need special contact lenses?
Rigid or scleral lenses can improve optics before surgery by creating a smooth optical surface. EyeWiki

10) Why are mornings often worse?
Overnight swelling of the surface can increase blur; hypertonic ointment at bedtime sometimes helps. DailyMed

11) Can artificial tears help my clarity?
Yes—preservative-free tears smooth the surface and can reduce scatter and irritation. DailyMed

12) Are steroids safe?
Short, supervised courses are useful for inflammation or after surgery, but they can raise eye pressure and carry risks; they must be monitored. FDA Access Data

13) Will diet cure MCD?
No. A surface-friendly diet supports comfort only; the disease itself is genetic. EyeWiki

14) How often should I be seen?
Follow your eye doctor’s schedule—typically regular visits to monitor vision, deposit depth, and plan surgery timing. EyeWiki

15) Is there any medicine I must avoid?
There’s no specific drug to avoid for MCD itself, but always tell your eye doctor about all medicines and supplements to coordinate safe care. EyeWiki

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 05, 2025.